JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes

  1. Schuyler Lee
  2. Haolin Liu
  3. Ryan Hill
  4. Chunjing Chen
  5. Xia Hong
  6. Fran Crawford
  7. Molly Kingsley
  8. Qianqian Zhang
  9. Xinjian Liu
  10. Zhongzhou Chen
  11. Andreas Lengeling
  12. Kathrin Maria Bernt
  13. Philippa Marrack
  14. John Kappler
  15. Qiang Zhou
  16. Chuan-Yuan Li
  17. Yuhua Xue
  18. Kirk Hansen
  19. Gongyi Zhang  Is a corresponding author
  1. National Jewish Health, United States
  2. School of Medicine, Univeristy of Colorado at Anschutz Medical Center, United States
  3. Xiamen Univeristy, China
  4. Children Hospital, United States
  5. China Agriculture University, China
  6. Duke University Medical Center, United States
  7. Max-Planck-Society, Germany
  8. School of Medicine, University of Pennsylvannia, United States
  9. Howard Hughes Medical Institute, National Jewish Health, United States
  10. University of California, Berkeley, United States
  11. Xiamen University, China
  12. School of Medicine, University of Colorado at Anschutz Medical Center, United States

Abstract

More than 30% of genes in higher eukaryotes are regulated by promoter-proximal pausing of RNA polymerase II (Pol II). Phosphorylation of Pol II CTD by positive transcription elongation factor b (P-TEFb) is a necessary precursor event that enables productive transcription elongation. The exact mechanism on how the sequestered P-TEFb is released from the 7SK snRNP complex and recruited to Pol II CTD remains unknown. In this report, we utilize mouse and human models to reveal methylphosphate capping enzyme (MePCE), a core component of the 7SK snRNP complex, as the cognate substrate for Jumonji domain-containing 6 (JMJD6)’s novel proteolytic function. Our evidences consist of a crystal structure of JMJD6 bound to methyl-arginine, enzymatic assays of JMJD6 cleaving MePCE in vivo and in vitro, binding assays, and downstream effects of Jmjd6 knockout and overexpression on Pol II CTD phosphorylation. We propose that JMJD6 assists bromodomain containing 4 (BRD4) to recruit P-TEFb to Pol II CTD by disrupting the 7SK snRNP complex.

Data availability

Diffraction data have been deposited in PDB under the accession code 6mev,All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Schuyler Lee

    Biomedical Research, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  2. Haolin Liu

    Biomedical Research, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  3. Ryan Hill

    Genetics and Biochemistry, School of Medicine, Univeristy of Colorado at Anschutz Medical Center, Aurora, United States
    Competing interests
    No competing interests declared.
  4. Chunjing Chen

    School of Pharmaceutical Sciences, Xiamen Univeristy, Xiamen, China
    Competing interests
    No competing interests declared.
  5. Xia Hong

    Biomedical Research, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  6. Fran Crawford

    Biomedical Research, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  7. Molly Kingsley

    Pediatrics, Children Hospital, Aurora, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5921-3743
  8. Qianqian Zhang

    State Key Laboratory of Agrobiotechnology, China Agriculture University, Beijing, China
    Competing interests
    No competing interests declared.
  9. Xinjian Liu

    Department of Dermatology, Duke University Medical Center, Durham, United States
    Competing interests
    No competing interests declared.
  10. Zhongzhou Chen

    State Key Laboratroy of Agrobiotechnology, China Agriculture University, Beijing, China
    Competing interests
    No competing interests declared.
  11. Andreas Lengeling

    Adminstrative Headquaters, Max-Planck-Society, Munich, Germany
    Competing interests
    No competing interests declared.
  12. Kathrin Maria Bernt

    Pediatrics, School of Medicine, University of Pennsylvannia, Philadelphia, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0691-356X
  13. Philippa Marrack

    Howard Hughes Medical Institute, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1883-3687
  14. John Kappler

    Howard Hughes Medical Institute, National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  15. Qiang Zhou

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7202-3947
  16. Chuan-Yuan Li

    Department of Dermatology, Duke University Medical Center, Durham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0418-6231
  17. Yuhua Xue

    Innovation Center of Cell Signaling Network, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China
    Competing interests
    No competing interests declared.
  18. Kirk Hansen

    Genetics and Biochemistry, School of Medicine, University of Colorado at Anschutz Medical Center, Aurora, United States
    Competing interests
    No competing interests declared.
  19. Gongyi Zhang

    Biomedical Research, National Jewish Health, Denver, United States
    For correspondence
    zhangg@njhealth.org
    Competing interests
    Gongyi Zhang, has shares in NB Life Laboratory LLC, Colorado.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3010-3804

Funding

National Cancer Institute (CA201230)

  • Kathrin Maria Bernt

National Institute of Allergy and Infectious Diseases (AI007405)

  • Schuyler Lee

National Institute of Allergy and Infectious Diseases (AI074491)

  • Haolin Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Lee et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,194
    views
  • 386
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Schuyler Lee
  2. Haolin Liu
  3. Ryan Hill
  4. Chunjing Chen
  5. Xia Hong
  6. Fran Crawford
  7. Molly Kingsley
  8. Qianqian Zhang
  9. Xinjian Liu
  10. Zhongzhou Chen
  11. Andreas Lengeling
  12. Kathrin Maria Bernt
  13. Philippa Marrack
  14. John Kappler
  15. Qiang Zhou
  16. Chuan-Yuan Li
  17. Yuhua Xue
  18. Kirk Hansen
  19. Gongyi Zhang
(2020)
JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes
eLife 9:e53930.
https://doi.org/10.7554/eLife.53930

Share this article

https://doi.org/10.7554/eLife.53930

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    Shinichi Kawaguchi, Xin Xu ... Toshie Kai
    Research Article

    Protein–protein interactions are fundamental to understanding the molecular functions and regulation of proteins. Despite the availability of extensive databases, many interactions remain uncharacterized due to the labor-intensive nature of experimental validation. In this study, we utilized the AlphaFold2 program to predict interactions among proteins localized in the nuage, a germline-specific non-membrane organelle essential for piRNA biogenesis in Drosophila. We screened 20 nuage proteins for 1:1 interactions and predicted dimer structures. Among these, five represented novel interaction candidates. Three pairs, including Spn-E_Squ, were verified by co-immunoprecipitation. Disruption of the salt bridges at the Spn-E_Squ interface confirmed their functional importance, underscoring the predictive model’s accuracy. We extended our analysis to include interactions between three representative nuage components—Vas, Squ, and Tej—and approximately 430 oogenesis-related proteins. Co-immunoprecipitation verified interactions for three pairs: Mei-W68_Squ, CSN3_Squ, and Pka-C1_Tej. Furthermore, we screened the majority of Drosophila proteins (~12,000) for potential interaction with the Piwi protein, a central player in the piRNA pathway, identifying 164 pairs as potential binding partners. This in silico approach not only efficiently identifies potential interaction partners but also significantly bridges the gap by facilitating the integration of bioinformatics and experimental biology.